These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14633663)

  • 1. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat.
    Nakaji M; Yano Y; Ninomiya T; Seo Y; Hamano K; Yoon S; Kasuga M; Teramoto T; Hayashi Y; Yokozaki H
    Carcinogenesis; 2004 Mar; 25(3):389-97. PubMed ID: 14633663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.
    Miki A; Yano Y; Kato H; Seo Y; Kuriyama M; Azuma T; Hayashi Y
    Int J Oncol; 2008 Mar; 32(3):603-8. PubMed ID: 18292937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
    Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
    Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
    Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
    Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
    Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats.
    Chakraborty T; Chatterjee A; Dhachinamoorthi D; Srivastawa S; Panayappan L; Chatterjee M
    Environ Mol Mutagen; 2006 Oct; 47(8):603-15. PubMed ID: 16878318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.
    Maruyama S; Nagasue N; Dhar DK; Yamanoi A; El-Assal ON; Satoh K; Okita K
    Clin Cancer Res; 2001 Jul; 7(7):2096-104. PubMed ID: 11448929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model.
    Perra A; Pibiri M; Sulas P; Simbula G; Ledda-Columbano GM; Columbano A
    Carcinogenesis; 2008 Jan; 29(1):161-8. PubMed ID: 17893235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
    Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
    Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.